Industry Experience of Multi-Stakeholder Early Advice Consultations, PPT by J. Anderson

Presentation at ISPOR Europe, Nov. 2011, by James S. Anderson, MA, MBA, European Partnerships Director, Government Affairs, Public Policy and Patient Advocacy, GlaxoSmithKline, Brentford, UK

You might also be interested in:

Proposed HTA Regulation Gets Warm Welcome from Trade Groups June 27, 2018
HTA in Europe: Key Success Factors for Positive HTA Recommendations June 21, 2018
Value-Based Solutions, Partnerships Announced at HIMSS 2018 March 14, 2018
Some Top Quotes From National Policy and Advocacy Summit on… April 30, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018
ISPOR Seeks Input for New HEOR Competencies Framework May 8, 2018